To explore the impacts of TP53 mutation in ESCC progression, we incorporated the alterations of significantly upregulated proteins (SUPs, Wilcoxon rank-signed test, FDR < 0.05) (Supplementary Fig. 4i). Here, TP53 is linked to esophageal squamous cell carcinoma.